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ates of deceased organ donation for the purposes of transplantation in the UK are amongst the lowest in the western world. 1 The incidence of end-organ failure that can be successfully treated with transplantation has risen every year for the last decade, resulting in an ever widening gap between those in need of a life-saving or life-transforming transplant and the number of patients whose wish to donate after death is currently being identified and fulfilled. 2 In turn, this has led to restricted access to some transplant waiting lists, increasing reliance on living donation programmes, transplant 'tourism', and at least a thousand avoidable deaths each year. Issues are particularly severe for patients from minority ethnic backgrounds, who comprise 25% of those on transplant waiting lists, 8% of the total population but only 3% of all deceased organ donors. While there will never be sufficient deceased organ donors to match the rising incidence of endstage renal disease, it is the comparative data on deceased donation around the world, expressed in terms of donors per million of population per year, that form the basis for the conviction that rates in the UK could be substantially improved (Figure 1) .
The Organ Donation Taskforce was assembled in 2006 with a remit to 'identify barriers to donation and transplantation and recommend solutions within existing operational and legal frameworks in England,' and published its conclusions in January 2008. 3 The 14 recommendations contained within the report, summarised in Table 1 , were accepted in full by health ministers from all four administrations of the UK, with substantial funding pledged for their implementation. Responsibility for implementation has been split between NHS Blood and Transplant (NHSBT) and the Departments of Health. NHSBT has responsibility for establishing a national organ donation and transplant organisation (to replace UK Transplant), the appointment and professional development of donation champions, reorganisation of donor transplant co-ordination, review of organ retrieval arrangements and development of effective and contemporary means of increasing public support for donation. The Department of Health in England, supported by representatives from other administrations, has a more strategic role that includes defining a sound ethical and legal framework for deceased donation, developing workable performance management arrangements, identifying and meeting the training needs of all clinical staff who might be involved in organ donation and finally, establishing appropriate modes of recognition for those who donate after their death.
While many of the recommendations of the Taskforce report concern process at a national level, deceased donation occurs in acute hospitals -in intensive care units (ICUs) and departments of emergency medicine -and it is these areas that should receive the greatest support and attention. Indeed, the work of the central agencies, both NHSBT and the Departments of Health, is inevitably supportive or enabling in its nature, and will only be effective if it changes what happens in hospitals, be it the approach of clinical staff to donation or the response from members of the public to it (Figure 2) . In this regard, the very Clinical leads for organ donation: making it happen in hospitals PG 
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The report from the Organ Donation Taskforce into the relatively poor rates of donation in the UK called for a complete overhaul of the processes that currently support the identification, referral and management of potential organ donors dying in our hospitals. Although some of the specific recommendations of the Taskforce refer to the responsibilities of national bodies such as the Department of Health or NHS Blood and Transplant, at the very heart of the Taskforce report are those recommendations that are concerned with how the option of donation is made available to patients when they die. Thus, the Taskforce recommended that donation should be a component of end-of-life care, that brainstem death should be diagnosed wherever possible and that potential donors should always be referred according to defined minimum criteria and regardless of apparent donation potential. However, it was recognised that this was unlikely to happen unless every hospital had a team to make it possible -the Donation Committee -that was chaired and driven by a non-clinical champion, enhanced by a donor transplant co-ordinator and lead by a clinician. This paper develops these themes and describes, by focusing on a collaborative relationship between donor transplant co-ordinators and clinical leads for organ donation, how real improvements in the number of organ donors might be achieved. The Taskforce was clear that none of these actions in isolation would be sufficient. For instance, while the need for clinical leadership is self evident because the possibility of organ donation is a relatively infrequent event for many hospitals, it was recognised that these efforts would be enhanced if clinicians were able to make better use of the skills and knowledge base of donor transplant co-ordinators. However, it was acknowledged that the close professional allegiances that many DTCs had with local transplant services might be an obstacle to establishing such collaborative relationships. For this, as well as for other reasons, the Taskforce called for a complete overhaul of donor transplant co-ordination, specifically recommending that they should lose any involvement in recipient work, and instead develop closer primary professional affiliations with those who care for potential donors and their families. The Taskforce also recommended a substantial increase in the number of DTCs, not only to provide them with a tolerable and sustainable working life, but also to allow each hospital to develop a functional and productive relationship with an assigned coordinator. Finally, it was obvious to the Taskforce that senior hospital executives were largely oblivious to the operational and strategic difficulties associated with organ donation within their organisation, and that without such oversight real changes in practice might be difficult to achieve and sustain. It was therefore also recommended that every hospital should have a Donation Committee chaired by a non-clinical champion. The primary remit of the Donation Committee will be to support the work of the clinical lead and embedded coordinator, and to ensure that local donation activity is reviewed on a regular basis through the organisation' s normal governance processes.
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These recommendations, when viewed together, describe the fundamental vision of the Taskforce, namely that significant increases in donation rates from individual hospitals will only be achieved if there is established a functional collaboration between clinical leads for donation and embedded donor transplant co-ordinators that is integrated into the core business of the hospital by the Donation Committee. There is no single solution to the current shortage of deceased organ donors, although the specific areas in which rates of donation might be increased are now becoming clearer, 4 in part through the information that is available from the national Potential Donor Audit (PDA). 5 These key areas of practice are summarised in Table 2 . As a starting point, the collaborative will be encouraged to review local PDA data and from this to develop an action plan that will both address the specific opportunities that have been identified and also resolve the likely obstacles that might be encountered. For many acute hospitals this will include:
• Support for donation from departments of emergency medicine, based upon the principle that where someone dies in an acute hospital should not of itself detract from their potential to donate after death.
• Support for donation after cardiac death, based upon the proposition that the manner of death per se should not adversely influence an individual' s opportunity to donate if such a process is medically feasible and professionally and ethico-legally acceptable. 6 • A thorough appraisal on how best to support families when they are asked to give their consent (or in Scotland, authorisation) for donation, based primarily upon respect for patient autonomy (as defined at law in the Human Tissue Act 2004 and the Human Tissue (Scotland) Act 2006). This is founded upon a conviction that the gap that currently exists between the level of public support for organ donation (85-90%) and actual family consent rates (61% in the UK overall) can and should be narrowed. 7 • The routine application of donor optimisation protocols that have been shown to increase the number and quality of organs that can be retrieved from a single donor, 8, 9 thereby maximising the gift that the donor and their family are able to make and avoiding the outcome that is perhaps least acceptable, viz for organs to be retrieved and transplanted, only to then prematurely fail through lack of physiological optimisation of the donor.
NHSBT
The clinical lead and embedded co-ordinator will be key members of the Donation Committee. In defining and developing the various initiatives that the initial review has identified, they will create an environment in which donation becomes a routine component of end-of-life care -'usual not unusual' to quote from the Taskforce report. It is expected that these principles will be integrated into local end-of-life policies and, in including the option of corneal and tissue donation, extend the opportunity of donation to many more patients. Some initiatives -those that include donation after cardiac death, for instance -will require careful and comprehensive consultation and high level policy endorsement from within the hospital, and the Donation Committee should have established links with the hospital executive to enable this. Another important role for the Donation Committee will be to scrutinise local PDA data, be responsible for the quality of the data, and to learn from circumstances where the potential for donation has been overlooked or ignored. Inevitably, there will be occasions where the clinical collaborative will need support in dealing with challenging behaviour, and in this regard the Taskforce was clear: clinical staff who have conscientious objections to donation cannot be expected to take part in the process, but neither can their objection be allowed to deny a patient or their family the opportunity of donation when it involves a process that has received local and national endorsement.
The Taskforce was aware that the large majority of critical care clinicians do much to support donation after death, and also recognised the many conflicting demands made upon their time and resources, particularly critical care beds. A specific issue of considerable importance is the admission of a gravely ill individual to ICU that seems directed more towards maintaining the potential for donation than providing a patient with any meaningful opportunity of functional survival. The Taskforce was determined to provide clinicians with a sound Special article Table 1 Recommendations of the report from the Organ Donation Taskforce. Blood and Transplant.   3 Resolve the ethical, legal and professional obstacles to deceased donation, and establish an independent, UK-wide donation ethics committee.
& 2 Establish a UK-wide organ donation organisation within NHS

4
Make donation usual, not unusual. Appoint a clinical lead for organ donation within each acute hospital, to be supported by a hospital Donation Committee. Establish donation as a routine component of end-of-life care.
5
Implement and monitor effectiveness of minimum criteria for the identification and referral of all potential donors.
6 Donation activity in all acute hospitals should be monitored. The hospital Donation Committee should report on this activity to the trust board through their clinical governance process. These reports should be part of the assessment of hospital performance through the relevant healthcare regulator. Benchmark data from other hospitals should be made available.
7
Brainstem death testing should be carried out wherever possible, even if organ donation is considered an unlikely outcome.
8
Remove financial disincentives to organ donation.
9
The current network of donor transplant co-ordinators (DTCs) should be expanded and strengthened. Additional DTCs should be recruited, and all should be centrally employed by the National Organ Donation Organisation. DTCs should have closer working relationships with critical care units, and work with the local clinical leads for donation to collaboratively deliver the objectives of the Taskforce report locally.
10
There should be a UK-wide network of organ retrieval teams, resourced to ensure timely and high quality organ retrieval from both heart beating and non-heart beating donors and accountable to the National Organ Donation Organisation.
11
All staff involved in the donation pathway should receive regular and mandatory training in the principles of donation.
12
Appropriate ways should be developed to both publicly and privately recognise individual donors, including national memorials, local initiatives and personal follow-up to donor families.
13
There is an urgent need to both identify and implement the most effective means of increasing public awareness of the benefits of donation and transplantation and translating this into increasing family consent rates for donation.
14 The Department of Health and Ministry of Justice should develop formal guidelines for coroners/procurators fiscal concerning organ donation.
professional framework for donation after death, similar to the statement that supports practice in Australia. 10 A UK-wide Donation Ethics Committee will be established by the end of 2009 and the current position in law regarding the best interests of a potential organ donor who is dying but not yet dead is being clarified. 11 More practically, NHSBT is now reimbursing hospitals for the costs incurred when caring for a brainstem dead or potential non-heart beating donors, not as some perverse financial incentive for donation but in recognition of the operational impact that a deceased donor can have on anaesthetic and critical care services. The Donation Committee will have an important role in establishing the importance of organ donation within an organisation -to see donation recognised as part of its 'core business' -even though the benefits of individual cases may not be felt locally. Eighty percent of donors come from 20% percent of acute hospitals in the UK. Although organ donation will continue to be an infrequent activity for many hospitals, nevertheless every hospital needs to be in a position to identify and refer potential donors. Recommendation five of the Taskforce report calls for a UK-wide introduction of minimum notification criteria, which are as follows:
• 'When no further treatment options are available or appropriate and there is a plan to confirm death by neurological criteria, the DTC should be notified as soon as sedation/analgesia is discontinued, or immediately if the patient never received sedation/analgesia. This notification should take place even if the attending clinical staff believe that donation might be contra-indicated or inappropriate. • In the context of catastrophic neurological injury, when no further treatment options are available or appropriate and there is no intention to confirm death by neurological criteria, the DTC should be notified when a decision has been made by a consultant to withdraw active treatment and this has been recorded in a dated, timed and signed entry in the case notes. This notification should take place even if the attending clinical staff believe that death cannot be diagnosed by neurological criteria, or that donation after cardiac death might be contra-indicated or inappropriate.' Turnover of junior medical and nursing staff is such that donation should be incorporated into departmental education, audit and professional development programmes and it is anticipated that the clinical lead and embedded co-ordinator will play a key role in ensuring the delivery of such programmes. This will thereby contribute to an element of the Taskforce' s recommendation that there should be training for all clinical staff likely to be involved in the treatment of potential organ donors. To support both this and other aspects of the role of the clinical lead, NHSBT (in collaboration with the Department of Health) will soon be embarking upon a national professional development programme for clinical leads and the chairs of hospital Donation Committees. The output of this programme will be a national framework for donation that can be consistently applied to the highest of standards across the country. This framework will be available in hard copy format, and also provided on-line as part of the Map of Medicine. 12 Broader training initiatives will ensure that aspects
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Brainstem death testing The Potential Donor Audit (PDA) estimates that there are as many as 350 patients each year who are likely to be brainstem dead but in whom tests are not performed. If this group of patients have the same donation potential as those whose death is confirmed on neurological grounds then this would represent as many as 170 extra donors, and over 600 extra transplants, each year
Introduction of minimum The PDA identifies around 130 patients each year who are confirmed to be brainstem dead but for whom the option referral criteria of donation is either not considered, or if it is, not presented to the potential donor's family. Although there may be several legitimate reasons why donation is not considered, it seems inevitable that there exists some missed potential in this group.
Consent
Consent is the biggest single obstacle to deceased donation in the UK. An overall consent rate in the UK of 61% compares with rates of 75-85% in mainland Europe. 1 Were levels of consent in the UK to match the apparent level of public support for donation there would be an additional 250 donors and 900+ transplants each year.
Donation from
The PDA reveals that the incidence of brainstem death that is diagnosed on ICUs has declined over the last five Departments of years. While this will in part represent advances in the management of severe brain injury (eg decompressive Emergency Medicine craniectomy, endovascular protection of cerebral aneurysms, stroke thrombolysis), it may also be a reflection of inexorable pressure on critical care capacity and uncertainty about the ethics and lawfulness of transferring a gravely ill patient from a department of emergency medicine to an ICU simply to facilitate donation. Pilot schemes around the country suggest that many departments of emergency medicine have a significant donation potential.
Donation after Cardiac
There has been an 8-fold increase in controlled DCD (non heart beating organ donation) in the UK over the last Death (DCD) decade. However, many units remain uneasy over this mode of donation, while other areas have no retrieval capacity to support it. As a result, as many as 50% of patients dying in ICUs currently do not have access to this option of donation after death.
Donor optimisation
International evidence suggests that significant increases in both the number and quality of retrieved organs can protocols be achieved through the application of best practice donor management protocols, with the greatest increases being for the thoracic organs. Clinical leads will be encouraged to develop policies that enable heart beating brainstem donors to be consistently managed to these high standards. Table 2 Areas of practice where donation rates might be significantly increased of donation are included into the curricula of Schools of Medicine and Nursing, as well as being covered in greater depth in relevant specialist training schemes, thereby providing the foundation of good practice as it relates to organ donation for future generations of clinical staff. Clinical leads will need time to do the job and NHSBT is offering funding for a minimum of one programmed activity per week to allow this role to be incorporated into an individual' s job plan. (It should be emphasised that these are hospital appointments, and that the commissioning relationship that follows is between NHSBT and the employing hospital, not the individual clinician). However, support for the clinical leads is not restricted to simply resourcing time. As the body of clinical leads grows, a regional network of clinical leads will be established which in turn will feed into a national representative group. It is envisaged that this network will develop close links with local DTC teams, and that a true collaborative approach to organ donation -the key to successful models of donation elsewhere in the world -will thereby be established in the UK. To quote from the Taskforce report one final time:
'These issues [donor identification and referral, donor coordination and organ retrieval arrangements] should not be particularly difficult, or even that costly to resolve. Overcoming them will require leadership, boldness and willingness to change established practice. The prize for doing so is considerable. ' Clinical leads for organ donation will be at the very heart of any improvements that are made -this is our challenge and our very great opportunity.
